BEVACIZUMAB RELATED ADVERSE EVENTS IN PATIENTS AFFECTED BY METASTATIC COLORECTAL CANCER: A META-ANALYSIS

被引：0
|
作者：
Cinquini, Michela [1 ]
Galfrascoli, Elena [2 ]
Rossi, Antonio [3 ]
Manazza, Andrea [4 ]
Damia, Giovanna [5 ]
Banna, Giuseppe [6 ]
Tosoni, Alicia [7 ]
Tiseo, Marcello [8 ]
Farina, Gabriella
Garassino, Marina Chiara
机构：
[1] Mario Negri Inst Pharmacol Res, New Drug Dev Strategies Lab, Milan, Italy
[2] Hosp Pharm, Fatebenefratelli & Ophthalm Hosp, Milan, Italy
[3] SG Moscati Hosp, Avellino, Italy
[4] CeRMS, Mol Oncol Lab, Turin, Italy
[5] Mario Negri Inst Pharmacol Res, Mol Pharmacol Lab, Milan, Italy
[6] Vittorio Emanuele Hosp, Catania, Italy
[7] Maggiore Hosp, Bologna, Italy
[8] Maggiore Hosp, Parma, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Bevacizumab related adverse events in patients affected by metastatic colorectal cancer: a meta-analysis
    Galfrascoli, E.
    Cinquini, M.
    Rossi, A.
    Manazza, A.
    Damia, G.
    Banna, G.
    Tosoni, A.
    Tiseo, M.
    Farina, G.
    Garassino, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 343 - 343
  • [2] Bevacizumab related adverse events in patients affected by metastatic colorectal cancer: a meta-analysis
    Galfrascoli, Elena
    Garassino, Marina C.
    Cinquini, Michela
    Rossi, Antonio
    Manazza, Andrea
    Damia, Giovanna
    Farina, Gabriella
    Muserra, Gaetana
    PHARMACY WORLD & SCIENCE, 2010, 32 (02): : 239 - 239
  • [3] Treatment related severe and fatal adverse events with cetuximab in colorectal cancer patients: a meta-analysis
    Zhang, Di
    Ye, Junjie
    Xu, Tangpeng
    Xiong, Bin
    JOURNAL OF CHEMOTHERAPY, 2013, 25 (03) : 170 - 175
  • [4] Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer
    Shankaran, Veena
    Mummy, David
    Koepl, Lisel
    Blough, David
    Yim, Yeun Mi
    Yu, Elaine
    Ramsey, Scott
    CLINICAL COLORECTAL CANCER, 2013, 12 (03) : 204 - +
  • [5] An Updated Meta-Analysis of Fatal Adverse Events Caused by Bevacizumab Therapy in Cancer Patients
    Huang, Hongxin
    Zheng, Yayuan
    Zhu, Jianhong
    Zhang, Jingjing
    Chen, Huapu
    Chen, Xinggui
    PLOS ONE, 2014, 9 (03):
  • [6] Risk of antiangiogenic adverse events in metastatic colorectal cancer patients receiving aflibercept in combination with chemotherapy: A meta-analysis
    Ge, Pu
    Han, Chunyan
    Reyila, Abudurousuli
    Liu, Diyue
    Hong, Wenying
    Liu, Jiaxin
    Zhang, Jinzi
    Han, Xiao
    Li, Xialei
    Huang, Mengjie
    Fan, Siyuan
    Kaierdebieke, Ayidana
    Wu, Xiaoyu
    Huang, Xiaolu
    Guo, Weirui
    Liu, Siyu
    Bian, Ying
    MEDICINE, 2023, 102 (35) : E34793
  • [7] RISK OF FATAL ADVERSE EVENTS WITH BEVACIZUMAB IN LUNG CANCER PATIENTS TREATED WITH CHEMOTHERAPY: A META-ANALYSIS
    Ranpura, V.
    Hapani, S.
    Wu, S.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S94 - S94
  • [8] Bevacizumab improves survival in metastatic colorectal cancer patients with primary tumor resection: A meta-analysis
    Cao, Dedong
    Zheng, Yongfa
    Xu, Huilin
    Ge, Wei
    Xu, Ximing
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] Bevacizumab in combination with first-line chemotherapy in patients with metastatic colorectal cancer: a meta-analysis
    Hu, W.
    Xu, W. -S.
    Liao, X. -F.
    He, H. -J.
    MINERVA CHIRURGICA, 2015, 70 (06) : 451 - 458
  • [10] Bevacizumab improves survival in metastatic colorectal cancer patients with primary tumor resection: A meta-analysis
    Dedong Cao
    Yongfa Zheng
    Huilin Xu
    Wei Ge
    Ximing Xu
    Scientific Reports, 9
12345